Breast Cancer Patients Seek MDL For Hair Loss From Taxotere Cancer Drug

(August 2, 2016, 12:04 PM EDT) -- WASHINGTON, D.C. — Two plaintiffs on July 22 asked a federal judicial panel to centralize 33 federal lawsuits filed by them and other women who allege that the breast cancer chemotherapy drug Taxotere (docetaxel) causes permanent hair loss and that defendant Sanofi S.A. knew about the side effect but failed to warn about it (In Re: Taxotere [Docetaxel] Products Liability Litigation, MDL Docket No. 2740, JPMDL).

(Brief available. Document #28-160804-007B.)

In a brief filed with the Judicial Panel on Multidistrict Litigation (JPMDL), Veronica Smith and Kelly...
To view the full article, register now.